USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock
19.82 USD
+0.22 (+1.12%)
19.82 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to USNA. USNA was compared to 36 industry peers in the Personal Care Products industry. USNA has an excellent financial health rating, but there are some minor concerns on its profitability. USNA has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year USNA was profitable.
In the past year USNA had a positive cash flow from operations.
USNA had positive earnings in each of the past 5 years.
Each year in the past 5 years USNA had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.34%, USNA is in line with its industry, outperforming 58.33% of the companies in the same industry.
USNA has a Return On Equity of 3.22%. This is in the better half of the industry: USNA outperforms 66.67% of its industry peers.
The Return On Invested Capital of USNA (4.04%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for USNA is below the industry average of 12.46%.
The last Return On Invested Capital (4.04%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 4.04% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
The Profit Margin of USNA (1.86%) is better than 61.11% of its industry peers.
USNA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.58%, USNA is in line with its industry, outperforming 52.78% of the companies in the same industry.
USNA's Operating Margin has declined in the last couple of years.
The Gross Margin of USNA (79.18%) is better than 94.44% of its industry peers.
USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
Compared to 1 year ago, USNA has less shares outstanding
Compared to 5 years ago, USNA has less shares outstanding
Compared to 1 year ago, USNA has a worse debt to assets ratio.
2.2 Solvency
USNA has an Altman-Z score of 3.68. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
USNA has a Altman-Z score of 3.68. This is in the better half of the industry: USNA outperforms 72.22% of its industry peers.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.68 |
ROIC/WACC0.48
WACC8.46%
2.3 Liquidity
A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
USNA's Current ratio of 2.23 is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
USNA has a Quick ratio of 1.46. This is comparable to the rest of the industry: USNA outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. Growth
3.1 Past
USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.74%.
Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
The Revenue has been growing slightly by 5.88% in the past year.
The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
3.2 Future
USNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.69% yearly.
USNA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.77% yearly.
EPS Next Y-32.13%
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue Next Year8.32%
Revenue Next 2Y3.08%
Revenue Next 3Y2.77%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.11, the valuation of USNA can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 86.11% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.15. USNA is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.25, the valuation of USNA can be described as very reasonable.
Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 83.33% of the companies in the same industry.
USNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.22.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.25 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 97.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.39 |
4.3 Compensation for Growth
USNA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.82
+0.22 (+1.12%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners61.34%
Inst Owner Change0.66%
Ins Owners0.61%
Ins Owner Change0.05%
Market Cap362.31M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (100.71%)
Short Float %5.63%
Short Ratio2.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)-36.07%
PT rev (3m)-36.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.18%
EPS NY rev (1m)1.76%
EPS NY rev (3m)-33.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.64%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-3.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.25 | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | 11.49 | ||
| P/B | 0.69 | ||
| P/tB | 1.48 | ||
| EV/EBITDA | 3.39 |
EPS(TTM)1.96
EY9.89%
EPS(NY)2.14
Fwd EY10.81%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY8.7%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 4.04% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 13.62% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.68 |
F-Score5
WACC8.46%
ROIC/WACC0.48
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-32.13%
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.32%
Revenue Next 2Y3.08%
Revenue Next 3Y2.77%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year56.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 5 / 10 to USNA.
What is the valuation status for USNA stock?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.
How financially healthy is USANA HEALTH SCIENCES INC?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 7 / 10.
What is the earnings growth outlook for USANA HEALTH SCIENCES INC?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -32.13% in the next year.